Digital Vs. Decentralized Trials

Digital Vs. Decentralized Trials

2 Feb, 2022

40% of all cardiology clinical trials do not focus on the most at risk population, elderly patients.

Despite older age being a well-established factor associated with cardiovascular risk, the needs of this population remains underserved in product development for clinical trials.

The shift of clinical trials to a decentralized setting, not only digital, is crucial in collecting data from at risk patients by providing them accessibility to continuous data collection tools from the comfort of their own home.

Learn more about the differences between decentralized and digitized clinical trials, and the necessity of proper implementation.

Get in touch with the Happitech team